Literature DB >> 35197

Review of clinical studies on clobazam.

D Koeppen.   

Abstract

1 Clobazam was compared with placebo and diazepam in 45 double-blind studies. 2 Clobazam dosage ranged from 5 mg daily (paediatric patients) to 120 mg daily (psychiatric in-patients). Usual daily dosage in out-patient therapy ranged from 20-30 mg clobazam. 3 Treatment duration varied from a few days up to 3.5 years. The usual duration of treatment was 2-4 weeks. 4 Clobazam was shown to be an efficacious and well tolerated anxiolytic agent in various neurotic and psychosomatic disorders. 5 Dosages showing distinct anxiolytic effects in out-patient therapy did not impair psychomotor performance.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 35197      PMCID: PMC1429541          DOI: 10.1111/j.1365-2125.1979.tb04684.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  A preliminary evaluation of the anxiolytic activity of clobazam.

Authors:  K Sandler; D Brunswick; J Digiacomo; J Mendels
Journal:  Curr Ther Res Clin Exp       Date:  1977-01

2.  Clinical comparison of methyprylone and quinalbarbitone as hypnotics; sequential analysis used.

Authors:  T J THOMSON
Journal:  Br Med J       Date:  1958-11-08

3.  [Study in pediatrics of an anxiolytic drug: clobazam].

Authors:  P Guran
Journal:  Ann Pediatr (Paris)       Date:  1976-06

4.  [Clobazam (Frisium) in everyday practice. An open six-months' study of its efficacy and tolerance (author's transl)].

Authors:  E Radmayr; D Koeppen
Journal:  MMW Munch Med Wochenschr       Date:  1977-12-16

5.  Clobazam versus diazepam--a double-blind study in anxiety neurosis.

Authors:  D R Doongaji; A Sheth; J S Apte; P D Lakdawala; C B Khare; S S Thatte
Journal:  J Clin Pharmacol       Date:  1978-07       Impact factor: 3.126

6.  Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy.

Authors:  E H Uhlenhuth; K Rickels; S Fisher; L C Park; R S Lipman; J Mock
Journal:  Psychopharmacologia       Date:  1966

7.  Clobazam: uncontrolled and standard controlled clinical trials.

Authors:  T A Ban; M M Amin
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

8.  Evaluation of drug efficacy by a preference technic.

Authors:  H Jick; D Slone; B Dinan; H Muench
Journal:  N Engl J Med       Date:  1966-12-22       Impact factor: 91.245

9.  Effect of a new benzodiazepine derivate, clobazam, in anxious patients with gastrointestinal disorders.

Authors:  O Laudano; M Peralta; L Lujan; N Aparicio; J Moizeszowicz
Journal:  J Clin Pharmacol       Date:  1977-07       Impact factor: 3.126

10.  [Methodological problems of clinical trials of psychotropic drugs (author's transl)].

Authors:  H Heimann
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1975-09-18
View more
  8 in total

Review 1.  GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.

Authors:  Raman Sankar
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

Review 2.  Clobazam: pharmacological and therapeutic profile.

Authors:  G W Hanks
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 3.  Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.

Authors:  Jose de Leon; Edoardo Spina; Francisco J Diaz
Journal:  Ther Drug Monit       Date:  2013-02       Impact factor: 3.681

4.  PharmGKB summary: clobazam pathway, pharmacokinetics.

Authors:  Rachel Huddart; J Steven Leeder; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2018-04       Impact factor: 2.089

5.  Evaluation of the effects of clobazam, A 1,5 benzodiazepine, on mood and psychomotor performance in clinically anxious patients in general practice.

Authors:  M R Salkind; G W Hanks; J T Silverstone
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

6.  Single daily dose treatment of anxiety with clobazam or dipotassium clorazepate.

Authors:  T D Wallis; J C Vallé-Jones; J R Craven; G W Hanks; P D Stonier
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

7.  Clobazam: single or divided doses?

Authors:  C Arnau; J M Costa Molinari; C Piña; C Vallvé
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Effects of clobazam and clonazepam on saccadic eye movements and other parameters of psychomotor performance.

Authors:  C H van der Meyden; P R Bartel; D K Sommers; M Blom; L C Pretorius
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.